Search Results - "Antolín‐Amérigo, D."

Refine Results
  1. 1
  2. 2
  3. 3

    High Frequency of Smell and Taste Dysfunction in Health Care Professionals With COVID-19 Working in Allergy Departments by Antolín Amérigo, D, Cubero, J L, Colás, C, Alobid, I, Mullol, J, Valero, A

    “…Since the early stages of the novel coronavirus 2019 (SARS-CoV-2) outbreak, smell and/or taste dysfunction (STD) has been reported in 5% to 88% of COVID-19…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Validation of the Spanish Version of the Food Allergy Quality of Life Questionnaire-Parent Form (S-FAQLQ-PF) by Manso, L, Pineda, R, Huertas, B, Fernández-Rivas, M, Diéguez, M C, Cerecedo, I, Muriel, A, Fernández, F B, DunnGalvin, A, Antolín-Amérigo, D, De la Hoz, B

    “…Food allergy is an emerging health problem. Several questionnaires can be used to establish health-related quality of life (HRQOL) in food allergy patients…”
    Get full text
    Journal Article
  8. 8

    Consensus document on dog and cat allergy by Dávila, I., Domínguez‐Ortega, J., Navarro‐Pulido, A., Alonso, A., AntolínAmerigo, D., González‐Mancebo, E., Martín‐García, C., Núñez‐Acevedo, B., Prior, N., Reche, M., Rosado, A., Ruiz‐Hornillos, J., Sánchez, M. C., Torrecillas, M.

    Published in Allergy (Copenhagen) (01-06-2018)
    “…The prevalence of sensitization to dogs and cats varies by country, exposure time and predisposition to atopy. It is estimated that 26% of European adults…”
    Get full text
    Journal Article
  9. 9

    Current update on anaphylaxis: anaphylaxis management in recent guidelines by Antolín-Amérigo, D, Vidal-Albareda, C, González de Olano, D, de la Hoz-Caballer, B

    “…Anaphylaxis is a potentially fatal hypersensitivity reaction but frequently underrecognized. Although its incidence rates vary according to geographical…”
    Get full text
    Journal Article
  10. 10

    National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE‐II by Larenas‐Linnemann, D. E. S., AntolínAmérigo, D., Parisi, C., Nakonechna, A., Luna‐Pech, J. A., Wedi, B., Davila, I., Gómez, M., Levin, M., Ortega Martell, J. A., Klimek, L., Rosario, N., Muraro, A. M., Agache, I., Bousquet, J., Sheikh, A., Pfaar, O.

    Published in Allergy (Copenhagen) (01-03-2018)
    “…Background Since 1988, numerous allergen immunotherapy guidelines (AIT‐GLs) have been developed by national and international organizations to guide physicians…”
    Get full text
    Journal Article
  11. 11

    Positioning of Tezepelumab in Severe Asthma by Miralles-López, J C, Antolín-Amérigo, D, García-Moguel, I, Domínguez-Ortega, J, Delgado-Romero, J, Quirce, S

    “…Asthma is one of the most common chronic diseases and is estimated to be severe in 3%-10% of affected patients. There is a need for additional biologic…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Impact of Asthma Inhalers on Global Climate: A Systematic Review of Their Carbon Footprint and Clinical Outcomes in Spain by Montoro, J, Antolín-Amérigo, D, Izquierdo-Domínguez, A, Zapata, J J, González, G, Valero, A

    “…Pressurized metered-dose inhalers (pMDIs) exert an environmental impact resulting from CO2 emissions. Therapeutic alternatives with less environmental impact…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Impact Of "eHealth" in Allergic Diseases and Allergic Patients by Alvarez-Perea, A, Sánchez-García, S, Muñoz Cano, R, Antolín-Amérigo, D, Tsilochristou, O, Stukus, D R

    “…The emergence of new technology enables allergists and patients to compile data and receive feedback regarding key symptoms, risk behavior, and/or management…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Erythema multiforme induced by tramadol: an allergy assessment by Sánchez-González, M J, Barbarroja-Escudero, J, Antolín-Amérigo, D, Rodríguez-Rodríguez, M, Pericet Fernández, L, Medina, I, Bellón-Heredia, T, Alvarez-Mon, M

    “…The authors report a case of erythema multiforme (EM) induced by tramadol confirmed with an allergy work-up. EM is a severe inflammatory skin disorder caused…”
    Get full text
    Journal Article